Novo Nordisk A/S (NONOF)
38.93
+0.03
(+0.07%)
USD |
OTCM |
Oct 26, 16:00
Novo Nordisk Price : 38.93 for Oct. 26, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 26, 2026 | 39.62 | 39.62 | 38.50 | 38.93 | 218138.0 |
| Oct 23, 2026 | 39.34 | 39.75 | 38.65 | 38.90 | 19500.00 |
| Oct 22, 2026 | 38.75 | 39.85 | 38.50 | 39.44 | 11656.00 |
| Oct 21, 2026 | 36.79 | 39.90 | 36.79 | 38.90 | 5030.00 |
| Oct 20, 2026 | 38.00 | 39.24 | 37.56 | 38.97 | 6787.00 |
| Oct 19, 2026 | 37.59 | 39.17 | 37.25 | 38.24 | 12322.00 |
| Oct 16, 2026 | 37.70 | 39.57 | 37.68 | 38.84 | 5885.00 |
| Oct 15, 2026 | 36.45 | 40.24 | 36.45 | 39.48 | 83965.00 |
| Oct 14, 2026 | 38.25 | 38.26 | 37.04 | 37.69 | 197313.0 |
| Oct 13, 2026 | 39.31 | 39.31 | 37.47 | 37.95 | 13241.00 |
| Oct 12, 2026 | 39.46 | 39.46 | 38.25 | 38.79 | 93219.00 |
| Oct 09, 2026 | 38.28 | 38.58 | 35.63 | 38.15 | 625258.0 |
| Oct 08, 2026 | 38.28 | 38.28 | 37.25 | 38.28 | 47383.00 |
| Oct 07, 2026 | 38.00 | 38.44 | 36.88 | 37.79 | 432508.0 |
| Oct 06, 2026 | 34.81 | 37.63 | 34.81 | 37.39 | 412575.0 |
| Oct 05, 2026 | 37.52 | 37.52 | 36.26 | 37.34 | 14768.00 |
| Oct 02, 2026 | 37.95 | 38.44 | 36.69 | 37.01 | 14285.00 |
| Oct 01, 2026 | 35.86 | 38.36 | 35.86 | 37.38 | 11125.00 |
| Sep 30, 2026 | 38.01 | 38.53 | 37.91 | 38.15 | 11176.00 |
| Sep 29, 2026 | 38.08 | 38.77 | 38.01 | 38.34 | 85378.00 |
| Sep 28, 2026 | 37.44 | 38.85 | 37.44 | 38.38 | 11179.00 |
| Sep 25, 2026 | 38.42 | 39.23 | 38.42 | 38.66 | 9735.00 |
| Sep 24, 2026 | 38.41 | 38.75 | 38.10 | 38.40 | 1.007M |
| Sep 23, 2026 | 39.54 | 39.54 | 36.40 | 38.25 | 15790.00 |
| Sep 22, 2026 | 39.50 | 40.04 | 39.01 | 39.32 | 6521.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eli Lilly & Co. | 1282.86 |
| ALK-Abello A/S | 36.50 |
| H. Lundbeck A/S | 6.85 |
| AstraZeneca PLC | 170.08 |
| GSK Plc | 50.95 |
Price Related Metrics
| PE Ratio | 9.514 |
| PS Ratio | 3.363 |
| PEG Ratio | 0.755 |
| Price to Book Value | 5.085 |
| Price to Free Cash Flow | 23.48 |
| Earnings Yield | 10.51% |
| Market Cap | 172.09B |
| PEGY Ratio | 0.5523 |
| Operating PE Ratio | 7.412 |
| Normalized PE Ratio | 9.145 |